CSIMarket
 
Brainsway Ltd   (BWAY)
Other Ticker:  
 
 
Price: $6.0600 $0.25 4.303%
Day's High: $6.4 Week Perf: -3.04 %
Day's Low: $ 5.99 30 Day Perf: -15.13 %
Volume (M): 191 52 Wk High: $ 7.62
Volume (M$): $ 1,155 52 Wk Avg: $3.84
Open: $6.18 52 Wk Low: $1.38



 Market Capitalization (Millions $) 202
 Shares Outstanding (Millions) 33
 Employees -
 Revenues (TTM) (Millions $) 27
 Net Income (TTM) (Millions $) 13
 Cash Flow (TTM) (Millions $) 17
 Capital Exp. (TTM) (Millions $) 0

Brainsway Ltd
Brainsway Ltd is a medical technology company that specializes in developing and marketing non-invasive brain stimulation systems for the treatment of various neurological and psychiatric disorders. The company is known for its deep transcranial magnetic stimulation (dTMS) technology, which delivers magnetic fields to specific areas of the brain. Brainsway's products are used by healthcare professionals worldwide for conditions such as major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The company aims to provide innovative and effective solutions to improve the quality of life for individuals suffering from these disorders.


   Company Address: 19 Hartum Street Jerusalem 9777518 MA
   Company Phone Number: 386-7001   Stock Exchange / Ticker: NASDAQ BWAY
   BWAY is expected to report next financial results on March 26, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

BrainsWay and Katies Way: A Dynamic Partnership Transforming Mental Health Treatment for Service Members and Veterans

Published Mon, Mar 18 2024 11:30 AM UTC

In the ever-evolving landscape of mental health treatment, BrainsWay Ltd and Katies Way have emerged as groundbreaking leaders, making significant strides in providing lifesaving mental health treatment nationally, with a specific focus on servicemembers, veterans, and their families. As BrainsWay Ltd experiences a slight decline in revenue, its partnership with Katies Way P...

Clinical Study

Advancements in Neurostimulation Treatment: BrainsWay's Clinical Evaluation of Rotational Field Deep TMS 360 Technology

Published Wed, Jan 10 2024 12:30 PM UTC

In recent years, advancements in neurostimulation treatments have gained significant attention in the field of mental health disorders. BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments, has recently announced the initiation of clinical evaluation for their groundbreaking stimulation technology called Rotational Field Deep TMS 360 (TF-DTMS)....

Product Service News

BrainsWay's Deep TMS Network Thrives in Western U.S. as Revenue Faces Headwinds

Published Tue, Dec 19 2023 12:30 PM UTC



BrainsWay Ltd., a renowned global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has announced its increased collaboration with a growing mental health treatment provider in the Western region of the United States. This collaboration has resulted in successive orders, ultimately leading to seven installed Deep Transcranial M...

Product Service News

BrainsWay Pioneers Advanced Deep TMS Technology to Revolutionize Mental Health Treatments in South Korea

Published Thu, Dec 7 2023 1:00 PM UTC

BrainsWay Announces Expansion of Deep TMS Technology in South Korea: Bolstering Mental Health Treatment Options
In a significant move towards advancing mental health treatments, BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments, has announced the expanded availability of its Deep Transcranial Magnetic Stimulation (Deep TMS) technology in...






 

Brainsway Ltd's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com